| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/07/2010 | US20100004173 Reconstituted surfactants having improved properties |
| 01/07/2010 | US20100003349 Portable, nitric oxide generator |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003199 Novel Protein Kinase C Therapy for the Treatment of Acute Lung Injury |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2728762A1 Rna antagonists targeting hsp27 |
| 01/07/2010 | CA2726221A1 Antiallergic marine biopolymers |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 01/06/2010 | EP2140882A1 Agent for treatment of pulmonary disease |
| 01/06/2010 | EP2140878A1 Vaccine against streptococcus pneumoniae |
| 01/06/2010 | EP2139881A1 Quinolines and their therapeutic use |
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139501A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 01/06/2010 | EP2139474A2 Transcription factor modulating compounds and methods of use thereof |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139331A1 Compositions and methods relating to novel compounds and targets thereof |
| 01/06/2010 | EP2139330A1 Methods involving aldose reductase inhibitors |
| 01/06/2010 | EP1687015B1 Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577199C Application of stomachic pill with cyperus and amomum |
| 01/06/2010 | CN100577186C Sinusitis pill |
| 01/06/2010 | CN100577166C Drug formulation having improved oral tolerability |
| 01/06/2010 | CN100577154C Effervescence tablet of 'Shuang Huanglian' and its preparation process thereof |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2368583C New medicament compositions based on anticholinergically-effective compounds and .beta.-mimetics |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2185397C Arylalkyl-diazinones |
| 12/31/2009 | US20090326070 Vinyl substituted fatty acids |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326003 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325958 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
| 12/31/2009 | US20090325953 P38 kinase inhibiting agents |
| 12/31/2009 | US20090325952 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 12/31/2009 | US20090325931 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 12/31/2009 | US20090325915 Crystalline Levosalbutamol Sulphate and Polymorphic Forms Thereof |
| 12/31/2009 | US20090325865 Liquid Formulations of Pegylated Growth Hormone |
| 12/31/2009 | US20090324734 Throat care composition |
| 12/31/2009 | US20090324724 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 12/31/2009 | US20090324723 Method of prophylaxis of infection |
| 12/31/2009 | US20090324699 Antihistamine-and corticosteroid-containing lipsome composition and its use for the manufacture of medicament for treating rhinitis and related disorders |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324591 Treatment of pulmonary disease conditions |
| 12/31/2009 | US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | US20090324510 Drug combinations for the treatment of respiratory tract diseases |
| 12/30/2009 | WO2009158625A2 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders |
| 12/30/2009 | WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 12/30/2009 | WO2009156082A1 Oxazolidinones for the treatment of chronic obstructive pulmonary disease (copd) and/or asthma |
| 12/30/2009 | WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 12/30/2009 | WO2009120803A3 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 12/30/2009 | WO2009112678A3 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/30/2009 | WO2009099998A3 Therapeutic treatment for lung conditions |
| 12/30/2009 | WO2009062118A3 Modulation of protein trafficking |
| 12/30/2009 | EP2138497A1 Novel adenine compound |
| 12/30/2009 | EP2138484A1 Fused bicyclic heteroaryl derivatives |
| 12/30/2009 | EP2138188A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 12/30/2009 | EP2138178A1 Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma |
| 12/30/2009 | EP2138054A1 Plant extract for the prevention or treatment of snoring and/or sleep apnoea |
| 12/30/2009 | EP2137215A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 12/30/2009 | EP2137155A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 12/30/2009 | EP2136804A1 Indolizine acetic acid derivatives as crth2 antagonists |
| 12/30/2009 | EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 12/30/2009 | EP1682542B1 Novel crystalline anhydride with anticholinergic effect |
| 12/30/2009 | EP1562949B1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/30/2009 | CN100574747C Pediatric paracetamol gelatin preparation for children and its preparing method |
| 12/30/2009 | CN100574746C Toothpaste containing notoginseng extract and preparing method |
| 12/30/2009 | CA2728652A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 12/30/2009 | CA2728112A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder |
| 12/29/2009 | US7638639 Substituted pyrrolidine and related compounds |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | US7638556 Freeze-dried product of N-[o-(p-pivaloyloxy benzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638540 Benzofuran compound and medicinal composition containing the same |
| 12/29/2009 | US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders |
| 12/29/2009 | US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |